Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial.

Journal: Lancet (London, England)

Publication date: 2021

Journal: Lancet (London, England)

Publication Year: 2021

Authors & Co-authors:  Lockman Brummel Ziemba Stranix-Chibanda McCarthy Coletti Jean-Philippe Johnston Krotje Fairlie

Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase 3 trial.

Journal: The lancet. HIV

Publication date: 2023

Journal: The lancet. HIV

Publication Year: 2023

Authors & Co-authors:  Chinula Ziemba Brummel McCarthy Coletti Krotje Johnston Knowles Moyo Stranix-Chibanda